PerkinElmer, Inc. (PKI)
(Delayed Data from NYSE)
$96.59 USD
+1.71 (1.80%)
Updated May 3, 2019 04:03 PM ET
After-Market: $96.59 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.59 USD
+1.71 (1.80%)
Updated May 3, 2019 04:03 PM ET
After-Market: $96.59 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
PerkinElmer (PKI) Up 2% Since Earnings Report: Can It Continue?
by Zacks Equity Research
PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Varian (VAR) Eclipse Software Named Category Leader by KLAS
by Zacks Equity Research
Varian Medical Systems (VAR) recently announced that its Eclipse treatment planning software has been named 2017 Category Leader for Oncology Treatment Planning by KLAS.
Varian (VAR) Wins Competitive Bid for Six Shanghai Hospitals
by Zacks Equity Research
Varian Medical Systems, Inc. (VAR) recently announced that it has won a competitive bid in Shanghai.
PerkinElmer (PKI) Misses Q4 Earnings & Revenue Estimates
by Zacks Equity Research
Waltham, MA-based PerkinElmer Inc (PKI) reported fourth-quarter 2016 earnings of 83 cents per share missing the Zacks Consensus Estimate of 86 cents
Will PerkinElmer (PKI) Disappoint this Earnings Season?
by Zacks Equity Research
PerkinElmer Inc. (PKI) is expected to report fourth-quarter 2016 results on Feb 2, 2017.
PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics
by Zacks Equity Research
PerkinElmer, Inc. (PKI) announced that it has entered into a definitive agreement to acquire Tulip Diagnostics Private Ltd.
Varian to Acquire PerkinElmer's Medical Imaging Business
by Zacks Equity Research
Varian Medical Systems, Inc. (VAR) recently announced an agreement to takeover the Medical Imaging business of Waltham, MA-based PerkinElmer, Inc. (PKI) for $276 million.
Is It Over Yet?
by Mark Vickery
By this time tomorrow we will have a new president. It feels like weathering a storm that's lasted a year and a half.
Top Stocks with Big Potential Catch-Up Moves
by Kevin Matras
Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include CSGP, CW, HLS, INGN and PKI.